Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Thinness 1Overweight 1Overnutrition 1Neoplasms, Plasma Cell 1Malnutrition 1Lymphoma, Follicular 1Lymphoma 1Feeding Behavior 1

Interventions

Rituximab 301Cyclophosphamide 241Peripheral Blood Stem Cell Transplantation 115fludarabine phosphate 111Filgrastim 93Etoposide 85Radiotherapy 81Lenalidomide 81Vincristine 79Prednisone 79Mycophenolic Acid 67Doxorubicin 62Whole-Body Irradiation 59Cyclosporine 59Bendamustine Hydrochloride 59Melphalan 57Tacrolimus 54Busulfan 52obinutuzumab 50fludarabine 50Cytarabine 49Methotrexate 45Antilymphocyte Serum 43Bortezomib 42Methylprednisolone 37Carmustine 37sargramostim 36ibritumomab tiuxetan 33ibrutinib 30Dexamethasone 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Nutrition Assessment × Lymphoid × Clear all
NCT05574842 2023-07-13

DBM

Debre Berhan University

Phase NA Completed
742 enrolled
Lymphoid

Feeding Behavior, Lymphoma, Follicular, Thinness, Malnutrition, Overnutrition, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡